Nucala 100 MG/ML syringeml

Ended Awarded

Contract number
SPE2DB24FYV36
Awardee
Awarding agency
Obligated
$22,715

Award facts

Contract value 100% obligated
$22,714.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $22,714.80 by the Defense Logistics Agency to provide NUCALA 100 MG/ML SYRINGEML. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items and medical products with a potential value of up to $5 million through December 2025. As a woman-owned small business and woman-owned business, DMS Pharmaceutical Group will fulfill this delivery order through November 2023 to support the medical needs of military treatment facilities operated by the Defense Logistics Agency.

Quick answers

Who was awarded contract SPE2DB24FYV36?

SPE2DB24FYV36 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2023.

How much is contract SPE2DB24FYV36 worth?

The government has obligated $22,715 on SPE2DB24FYV36.

Is contract SPE2DB24FYV36 an order under another contract?

Yes. SPE2DB24FYV36 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.

Was contract SPE2DB24FYV36 competed?

The extent of competition for SPE2DB24FYV36 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award